TORTI, Carlo
 Distribuzione geografica
Continente #
NA - Nord America 5.568
AS - Asia 2.614
EU - Europa 1.993
SA - Sud America 466
AF - Africa 67
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 11
Totale 10.733
Nazione #
US - Stati Uniti d'America 5.360
SG - Singapore 1.413
IT - Italia 883
CN - Cina 692
BR - Brasile 362
GB - Regno Unito 287
SE - Svezia 257
DE - Germania 213
CA - Canada 163
VN - Vietnam 145
IN - India 107
FI - Finlandia 77
HK - Hong Kong 63
NL - Olanda 51
MX - Messico 37
AR - Argentina 36
BD - Bangladesh 28
FR - Francia 28
CZ - Repubblica Ceca 27
ES - Italia 26
PL - Polonia 26
JP - Giappone 24
IQ - Iraq 22
ZA - Sudafrica 22
EC - Ecuador 21
RO - Romania 21
RU - Federazione Russa 21
TR - Turchia 21
UA - Ucraina 19
ID - Indonesia 18
SA - Arabia Saudita 17
VE - Venezuela 12
CL - Cile 10
CO - Colombia 10
UZ - Uzbekistan 10
A2 - ???statistics.table.value.countryCode.A2??? 9
AE - Emirati Arabi Uniti 8
AT - Austria 8
EG - Egitto 8
IL - Israele 8
PY - Paraguay 8
AU - Australia 6
ET - Etiopia 6
LT - Lituania 6
TN - Tunisia 6
EU - Europa 5
GR - Grecia 5
IE - Irlanda 5
KE - Kenya 5
NG - Nigeria 5
PE - Perù 5
AL - Albania 4
AM - Armenia 4
CH - Svizzera 4
DO - Repubblica Dominicana 4
IR - Iran 4
KR - Corea 4
NO - Norvegia 4
PK - Pakistan 4
BG - Bulgaria 3
DZ - Algeria 3
EE - Estonia 3
KZ - Kazakistan 3
LV - Lettonia 3
MA - Marocco 3
NP - Nepal 3
PH - Filippine 3
AZ - Azerbaigian 2
BE - Belgio 2
DK - Danimarca 2
GH - Ghana 2
JO - Giordania 2
MD - Moldavia 2
MY - Malesia 2
RS - Serbia 2
TO - Tonga 2
TT - Trinidad e Tobago 2
TZ - Tanzania 2
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
DM - Dominica 1
GA - Gabon 1
HN - Honduras 1
HR - Croazia 1
KI - Kiribati 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MZ - Mozambico 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TL - Timor Orientale 1
TV - Tuvalu 1
TW - Taiwan 1
Totale 10.732
Città #
Chandler 900
Singapore 570
Santa Clara 425
Hefei 397
Dallas 353
Milan 339
Princeton 334
Lawrence 332
Chicago 222
London 222
Wilmington 216
Ashburn 174
Munich 165
Ottawa 124
Des Moines 98
Boardman 72
Turku 63
Hong Kong 59
Los Angeles 56
Ho Chi Minh City 50
Rome 47
São Paulo 40
New York 37
Pune 35
Brooklyn 34
San Francisco 33
Hanoi 32
Norwalk 32
Guangzhou 31
Shanghai 31
Redwood City 29
Catanzaro 28
Council Bluffs 28
Olomouc 27
Palermo 24
The Dalles 23
Warsaw 22
Woodbridge 22
Chennai 20
Crotone 20
Houston 20
San Nicola Manfredi 20
Tokyo 20
Wuhan 20
Atlanta 17
Boston 17
Fairfield 17
Beijing 16
Naples 15
Stockholm 15
Phoenix 14
Shenzhen 14
Cosenza 13
Helsinki 13
Montreal 13
Charlotte 12
Hanover 12
Rende 12
Rui'an 12
Redmond 11
Seattle 11
Amsterdam 10
Johannesburg 10
Mexico City 10
Rio de Janeiro 10
Settingiano 10
Tashkent 10
Ankara 9
Guayaquil 9
Padova 9
Taranto 9
Ann Arbor 8
Baghdad 8
Columbus 8
Denver 8
Salvador 8
Bari 7
Belo Horizonte 7
Brasília 7
Haiphong 7
Jeddah 7
Quanzhou 7
Assago 6
Bogotá 6
Da Nang 6
Dhaka 6
Falls Church 6
Fayetteville 6
Jiaxing 6
Maryland Heights 6
Miami 6
New Delhi 6
Piracicaba 6
Reggio Calabria 6
Biên Hòa 5
Caracas 5
Catania 5
Ilhéus 5
Quito 5
Recife 5
Totale 6.360
Nome #
Severe hepatotoxicity during combination antiretroviral treatment: Incidence, liver histology, and outcome 105
Analysis of the persistence time of the SARS-CoV-2 virus in the cadaver and the risk of passing infection to autopsy staff 91
The Role of Gut Microbiota in the Clinical Outcome of Septic Patients: State of the Art and Future Perspectives 64
A case report of pneumomediastinum in a COVID-19 patient treated with high-flow nasal cannula and review of the literature: Is this a “spontaneous” complication? 63
Influence of genotype 3 hepatitis C coinfection on liver enzyme elevation in HIV-1-positive patients after commencement of a new highly active antiretroviral regimen: results from the EPOKA-MASTER Cohort. 60
A CASE REPORT OF SCHISTOSOMA HAEMATOBIUM INFECTION IN A PREGNANT MIGRANT RAISES CONCERNS ABOUT LACK OF SCREENING POLICIES. 60
Multidisciplinary approach to a septic COVID-19 patient undergoing veno-venous extracorporeal membrane oxygenation and receiving thoracic surgery 58
Ochrobactrum anthropi 57
Clinical characteristics and predictors of mortality associated with COVID-19 in elderly patients from a long-term care facility 57
Apparent inefficacy of hydroxychloroquine combined with azithromycin on SARS-CoV-2 clearance in an incident cohort of geriatric patients with COVID-19 54
The spike-specific TCRβ repertoire shows distinct features in unvaccinated or vaccinated patients with SARS-CoV-2 infection 53
Persistence of SARS-CoV-2 infection and viral intra- and inter-host evolution in COVID-19 hospitalized patients 53
Varicella zoster immunity loss in multiple sclerosis patient treated with ocrelizumab 52
Evolving phenotypes of non-hospitalized patients that indicate long COVID 52
A Rare Complication of Ascariasis: A Case of Acute Interstitial Nephritis 51
EFFICACY OF CEFIDEROCOL- VERSUS COLISTIN-CONTAINING REGIMEN FOR TREATMENT OF BACTEREMIC VENTILATOR-ASSOCIATED PNEUMONIA CAUSED BY CARBAPENEM-RESISTANT ACINETOBACTER BAUMANNII IN COVID-19 PATIENTS 51
Molecular recognition studies of dasabuvir, tegobuvir, and setrobuvir against natural Hepatitis C Virus NS5B polymerase variants. 51
Protein and vitamin B6 intake are associated with liver steatosis assessed by transient elastography, especially in obese individuals 49
Successful treatment with cefiderocol for compassionate use in a critically ill patient with XDR Acinetobacter baumannii and KPC-producing Klebsiella pneumoniae: a case report. 49
A randomized controlled trial to evaluate antiretroviral salvage therapy guided by rules-based or phenotype-driven HIV-1 genotypic drug-resistance interpretation with or without concentration-controlled intervention: The resistance and dosage adapted regimens (RADAR) study 48
HCV antibody prevalence and genotype evolution in a teaching hospital, Calabria Region, southern Italy over a decade (2008-2018) 48
Direct antimicrobial susceptibility testing (AST) from positive blood cultures using Microscan system for early detection of bacterial resistance phenotypes 48
SARS CoV-2 spike protein-guided exosome isolation facilitates detection of potential miRNA biomarkers in COVID-19 infections 47
Challenging clinical cases in HCV infection 47
Pursuing Later Treatment Options II (PLATO II) Project Team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord. Higher rates of triple-class virological failure in perinatally HIV infected teenagers compared with heterosexually infected young adults in Europe 46
Clinical outcomes of patients treated with intravenous zanamivir for severe influenza A(H1N1)pdm09 infection: a case report series. 46
Adiponectin serum level in chronic hepatitis C infection and therapeutic profile 45
Combined lymphocyte/monocyte count, D-dimer and iron status predict COVID-19 course and outcome in a long-term care facility 45
Therapy with RAS inhibitors during the COVID-19 pandemic 45
A king in the CASTLE? Optimum initial HIV protease inhibitor. 44
A randomized, controlled trial of triple antiviral therapy as initial treatment of chronic hepatitis C in HIV-infected patients 44
A comparison of three computational modelling methods for the prediction of virological response to combination HIV therapy 44
Analysis of dominant viral populations isolated from two pediatric patients infected by HCV genotype 4. 44
Role of the T2Dx magnetic resonance assay in patients with suspected bloodstream infection: a single-centre real-world experience 44
Virologic and resistance markers in HIV infection: rationale, state of ART and perspective in clinical practice 43
A new basal subfamily of mariner elements in Ceratitis rosa and other tephritid flies 43
Allozyme divergence and phylogenetic relationships among species of tephritid flies 43
A case report of nasopharyngeal carcinoma in a Caucasian Italian man 43
Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study 43
Adaptive optics optical coherence tomography at 120,000 depth scans/s for non-invasive cellular phenotyping of the living human retina 42
Factors associated with short-term changes in HIV viral load and CD4(+) cell count in antiretroviral-naive individuals 42
Adherence and plasma drug concentrations are predictors of confirmed virologic response after 24-week salvage highly active antiretroviral therapy 42
Back to the origin of HCV 2c subtype and spreading to the Calabria region (Southern Italy) over the last two centuries: A phylogenetic study 42
Dynamics of Viral Infection and Evolution of SARS-CoV-2 Variants in the Calabria Area of Southern Italy 42
Discussion on critical points for a tailored therapy to cure hepatitis C virus infection 41
Analysis of HIV-1 mutation patterns in patients failing antiretroviral therapy 41
Increasing clinical virulence in two decades of the Italian HIV epidemic 41
Response to combination antiretroviral therapy: variation by age - The Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study group 41
Prevalence of Antibiotic Resistance Over Time in a Third-Level University Hospital 40
A Randomized, Pilot Trial to Evaluate Glomerular Filtration Rate by Creatinine or Cystatin C in Naive HIV-Infected Patients After Tenofovir/Emtricitabine in Combination With Atazanavir/Ritonavir or Efavirenz 40
Acute respiratory distress syndrome after SARS-CoV-2 infection on young adult population: International observational federated study based on electronic health records through the 4CE consortium 39
Risk of Chronic Kidney Disease among Patients Developing Mild Renal Impairment during Tenofovir-Containing Antiretroviral Treatment 39
RegaDB: community-driven data management and analysis for infectious diseases 39
2018 update to the HIV-TRePS system: the development of new computational models to predict HIV treatment outcomes, with or without a genotype, with enhanced usability for low-income settings. 39
R211K and L214F ho not invariably confer high level phenotypic resistance to thymidine analogs in zidovndine-naive patients with M184V 38
HIV/HTLV co-infection: frequency and epidemiological characteristics among patients admitted to an Italian hospital 38
"Solving the puzzle" of current HAART: What key strategic trials are needed? 38
Exploratory analysis for the evaluation of lopinavir/ritonavir-versus efavirenz-based HAART regimens in antiretroviral-naive HIV-positive patients: results from the Italian MASTER Cohort 38
Effectiveness of adjunctive gabapentin in resistant bipolar disorder: Is it due to anxious-alcohol abuse comorbidity? 38
Knowledge of HIV infection and transmission: a knowledge, attitudes, beliefs and practices (KABP) survey among a sample of students at the "Magna Graecia", University of Catanzaro 38
Is neutrophil gelatinase associated lipocalin useful in hepatitis C virus infection? 38
Characteristics, management, and outcomes of elderly patients with diabetes in a covid-19 unit: Lessons learned from a pilot study 38
Genomic organization and characterization of the white locus of the Mediterranean fruitfly, Ceratitis capitata 37
The Disagreement Among Methods to Evaluate Glomerular Filtration Rate in HIV-Infected Patients Naive to Antiretroviral Therapy. 37
Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes 37
HIV-1 Subtype Is an Independent Predictor of Reverse Transcriptase Mutation K65R in HIV-1 Patients Treated with Combination Antiretroviral Therapy Including Tenofovir 37
Kaposi Sarcoma Risk in HIV-Infected Children and Adolescents on Combination Antiretroviral Therapy From Sub-Saharan Africa, Europe, and Asia 37
Is response to anti-hepatitis C virus treatment predictive of mortality in hepatitis C virus/HIV-positive patients? The Hepatitis C Working Group for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord 37
Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study 37
Listeria infection after treatment with alemtuzumab: A case report and literature review. would antibiotic prophylaxis be considered? 37
Oxygen therapy via high flow nasal cannula in severe respiratory failure caused by Sars-Cov-2 infection: a real-life observational study 37
HIV susceptibility to amprenavir: phenotype-based versus rules-based interpretations 36
A population-based database to study malignancies in HIV-infected patients in the Local Health Unit of Brescia (Northern Italy), period 1999-2009 36
Unboosted Atazanavir for Treatment of HIV Infection Rationale and Recommendations for Use 36
HIV-1 pharmacoresistance: clinical and therapeutic implications 36
Evolution of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy from 2000 to 2010 36
Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America 36
y CD4 Cell Count and the Risk of AIDS or Death in HIV-Infected Adults on Combination Antiretroviral Therapy with a Suppressed Viral Load: A Longitudinal Cohort Study from COHERE 36
Low compliance with hepatocellular carcinoma screening guidelines in hepatitis B/C virus co-infected HIV-patients with cirrhosis. 36
Incidence of AIDS-defining cancers and virus-related and non-virus-related non-AIDS-defining cancers among HIV-infected patients compared with the general population in a large health district of Northern Italy, 1999-2009 35
Intron size polymorphism of the Adh(1) gene parallels the worldwide colonization history of the Mediterranean fruit fly, Ceratitis capitata 35
Characterization and evolution of mariner elements from closely related species of fruit flies (Diptera : Tephritidae) 35
Genetic differentiation, gene flow and the origin of infestations of the medfly, Ceratitis capitata 35
Risk factors for myocardial infarction in HIV positive patients 35
Genetic aspects of the worldwide colonization process of Ceratitis capitata 35
Prospective evaluation of bone markers, parathormone and 1,25-(OH)(2) vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz 35
Modifications of health resource-use in Italy after the introduction of highly active antiretroviral therapy (HAART) for human immunodeficiency virus (HIV) infection. Pharmacoeconomic implications in a population-based setting 35
Genotyping for guiding drug choice in human immunodeficiency virus-infected children failing multiple antiretroviral treatment regimens 35
Characterisation of viro-immunlogical responses in a closely followed cohort oh heavily pretreated patients: evidence from the GenPheRex Study 35
Pharmacokinetics of efavirenz (EFV) alone and in combination therapy with nelfinavir (NFV) in HIV-1 infected patients 35
Evidence of Low Prevalence of Cystic Echinococcosis in the Catanzaro Province, Calabria Region, Italy. 35
Phylogenetic and Molecular Analyses of More Prevalent HCV1b Subtype in the Calabria Region, Southern Italy 35
Late-onset myocardial infarction and autoimmune haemolytic anaemia in a COVID-19 patient without respiratory symptoms, concomitant with a paradoxical increase in inflammatory markers: a case report 35
Role of IgG and IgM and proinflammatory aspecific markers in the diagnosis and prognosis of COVID-19 patients stratified by number of positive SARS-CoV-2 genes 35
Spike-specific T-cell responses in patients with COVID-19 successfully treated with neutralizing monoclonal antibodies against SARS-CoV-2 34
Are we doing enough for controlling tuberculosis and multi-drug resistance in an epicenter of the current migration emergency (Calabria Region, Southern Italy)? 34
Seroprevalence and age-related susceptibility of TORCH infections in childbearing age women: a 5-year cross-sectional retrospective study and a literature review 34
Utility of Molecular Identification and Quantitation of Bartonella Species with Species-Specific Real-Time PCR for Monitoring Treatment Response: A Case Series. 34
Early virological failure after tenofovir plus didanosine plus efavirenz combination in HIV-positive patients upon starting antiretroviral therapy 34
Current concerns in HIV antiretroviral therapy 34
Totale 4.294
Categoria #
all - tutte 151.299
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 151.299


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021268 0 0 91 19 17 31 16 32 34 16 3 9
2021/2022880 9 3 12 236 30 17 41 216 58 104 146 8
2022/20232.570 684 110 20 276 286 244 14 160 402 169 167 38
2023/20241.134 237 147 80 77 69 290 36 24 26 25 60 63
2024/20253.722 543 273 136 136 236 460 67 142 458 232 334 705
2025/20262.067 398 1.063 606 0 0 0 0 0 0 0 0 0
Totale 10.982